Drug recall: Voluntary Nationwide Recall: Tydemy (Lupin July)
Sep. 2023Important Notices
Lupin Pharmaceuticals Inc. has recalled two lots of Tydemy™ (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3 mg/0.03 mg/0.451 mg and Levomefolate Calcium Tablets 0.451 mg) because they did not pass stability testing, which could impact the effectiveness of the product. Taking an ineffective product could potentially result in unexpected pregnancy. Read the full text of the voluntary Tydemy recall.
Recent Announcements
Special notice: Important policy changes
Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.May 2025Important Notices
Provider OnLine Enhancements
Provider OnLine will be launching enhancements to the authorization process on April 18, 2025. The enhancement will include the following updates:Apr. 2025Important Notices
Fostering Trust in Vaccinations Through Shared Decision Making
Please join us for a live, CME-accredited webinar on Wednesday, June 4, from noon to 1 p.m. that will provide an overview of fostering trust in vaccinations through shared decision making.Apr. 2025Education/Webinars